Larvol Delta - Novartis-provides-update-on-delpacibart-etedesiran-deldesiran-Phase-III-HARBOR-study-for-the-treatment-of-myotonic-dystrophy-type-1-DM1

delpacibart etedesiran (EWF980) - Avidity Biosci

https://www.manilatimes.net/2026/09/08/tmt-newswire/globenewswire/novartis-provides-update-on-delpacibart-etedesiran-del-desiran-phase-iii-harbor-study-for-the-treatment-of-myotonic-dystrophy-type-1-dm1/2420151/amp

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next